Discontinuation of Efavirenz in Paediatric Patients: Why do Children Switch? - Wikidata - awgldk - TriplyDB

Discontinuation of Efavirenz in Paediatric Patients: Why do Children Switch?

Discontinuation of Efavirenz in Paediatric Patients: Why do Children Switch?

http://www.wikidata.org/entity/Q47404336

about

Discontinuation of Efavirenz in Paediatric Patients: Why do Children Switch?

http://www.wikidata.org/entity/Q47404336

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Discontinuation of Efavirenz in Paediatric Patients: Why do Children Switch?

@en

Discontinuation of Efavirenz in Paediatric Patients: Why do Children Switch?

@nl

type

label

Discontinuation of Efavirenz in Paediatric Patients: Why do Children Switch?

@en

Discontinuation of Efavirenz in Paediatric Patients: Why do Children Switch?

@nl

prefLabel

Discontinuation of Efavirenz in Paediatric Patients: Why do Children Switch?

@en

Discontinuation of Efavirenz in Paediatric Patients: Why do Children Switch?

@nl

P1433

Q47404336-71FBB45B-225C-417D-973C-467F57A36CA5

P1476

Q47404336-AB5C9283-9CB0-4563-A08D-2499CFEB14D0

P2093

Q47404336-100D5B7A-FF1C-48DB-A83A-72B10CD5BA07

Q47404336-54BE25A6-C1B6-4EE6-BC27-38C69547F014

Q47404336-E36643B1-5998-4A02-9568-4370FB7BFB37

Q47404336-F81EFF12-063F-49C6-BCCB-0E626F9D8D46

P2860

Q47404336-0CDE8E23-08D4-403A-9112-19578C2411A9

Q47404336-1D8BC444-F854-47F1-9FC6-1866AC8EA836

Q47404336-1F5319DC-AA27-4108-A2C4-A30EDBCB9C01

Q47404336-277CF1B6-65C0-423D-9918-2CA7FE5D770B

Q47404336-2974EE8B-A8C2-4A98-B27D-79C8CC6FDC0E

Q47404336-2FF66383-4D8B-4AEB-A80E-22CD5BB1FAB1

Q47404336-4E116AE6-982E-49EA-8658-BA5A2F557F4C

Q47404336-52A32BAA-5DC0-4535-9C6E-370CD7EF90B3

Q47404336-6C11FA1A-DB7D-4369-B990-57352E41C2B3

Q47404336-6F687DD5-E852-4A28-8591-6062FBC23EA6

P304

Q47404336-757D95DD-12ED-4DF1-8DC5-7B5B9AAB173A

P31

Q47404336-F53CC9CB-77E4-4040-A7C5-0A239546CF08

P356

Q47404336-71910ECA-6AF3-408F-AB37-2BB56649A65F

P433

Q47404336-880D006A-442E-4329-B210-B7F6F019EEBA

P478

Q47404336-111D6AAD-079B-491B-81B1-5DBB20B88EDD

P50

Q47404336-9F66B5F7-AEFB-49D6-BC44-4027C4CDD046

P577

Q47404336-8A42E066-AB18-4494-9CD9-D331E0E59D90

P698

Q47404336-8B07DF72-05A9-468A-A547-E084CD132E3C

P356

S40261-017-0605-1

P1433

Clinical Drug Investigation

P1476

Discontinuation of Efavirenz in Paediatric Patients: Why do Children Switch?

@en

P2093

Caroline Foster

http://www.w3.org/2001/XMLSchema#string

Eleri Williams

http://www.w3.org/2001/XMLSchema#string

Gareth Tudor-Williams

http://www.w3.org/2001/XMLSchema#string

Hermione Lyall

http://www.w3.org/2001/XMLSchema#string

P2860

Adherence to antiretroviral therapy in adolescents living with HIV: systematic review and meta-analysis

The convergence of therapeutic drug monitoring and pharmacogenetic testing to optimize efavirenz therapy

Association between efavirenz as initial therapy for HIV-1 infection and increased risk for suicidal ideation or attempted or completed suicide: an analysis of trial data.

Management of the adverse effects of antiretroviral therapy and medication adherence.

Long-term virological outcome in children on antiretroviral therapy in the UK and Ireland.

Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection.

Interpatient variability in the pharmacokinetics of the HIV non-nucleoside reverse transcriptase inhibitor efavirenz: the effect of gender, race, and CYP2B6 polymorphism

Case report: Severe central nervous system manifestations associated with aberrant efavirenz metabolism in children: the role of CYP2B6 genetic variation.

BREATHER (PENTA 16) short-cycle therapy (SCT) (5 days on/2 days off) in young people with chronic human immunodeficiency virus infection: an open, randomised, parallel-group Phase II/III trial.

First-line antiretroviral drug discontinuations in children

P304

231-238

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40261-017-0605-1

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

38

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29181714

http://www.w3.org/2001/XMLSchema#string